Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy

Cancer immunotherapy, which reactivates weakened immune cells of cancer patients, has yielded great success in recent years. Among immunotherapeutic agents, immune checkpoint inhibitors have been of particular interest and have gained approval by the FDA for treatment of cancers. Immune checkpoint b...

Descripción completa

Detalles Bibliográficos
Autores principales: Makuku, Rangarirai, Khalili, Neda, Razi, Sepideh, Keshavarz-Fathi, Mahsa, Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925068/
https://www.ncbi.nlm.nih.gov/pubmed/33681388
http://dx.doi.org/10.1155/2021/6661406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925068/
https://www.ncbi.nlm.nih.gov/pubmed/33681388
http://dx.doi.org/10.1155/2021/6661406

Ejemplares similares